<DOC>
	<DOC>NCT00882856</DOC>
	<brief_summary>Clozapine-induced sinustachycardia occurs in 25% of patients treated with clozapine and sustained sinustachycardia might be a risk factor for dilated cardiomyopathy. This double-blinded cross over placebo controlled study investigate whether 10 mg bisoprolol are efficient in treating clozapine-induced sinustachycardia measured as heart rate, heart rate variability, QTc and T-wave morphology.</brief_summary>
	<brief_title>Treating Clozapine-induced Sinustachycardia With Bisoprolol</brief_title>
	<detailed_description />
	<mesh_term>Clozapine</mesh_term>
	<mesh_term>Bisoprolol</mesh_term>
	<criteria>Treated with clozapine &gt; 3 months and minimum 100 mg/day Fixed dose 14 days before inclusion Heart rate &gt; 100 (ECG) Pregnancy test negative Clozapineinduced sinustachycardia documented by ECG or case record Sexual abstinence or contraception Informed consent Substance abuse Physical diseases, contraindications for clozapine or bisoprolol Asthma or chronic obstructive lung disease Blood pressure &lt; 100/60 or recent history of syncopes QTc&gt;500 ms, SAblock, AV block II or III Restrictions by Danish mental act Allergic to clozapine or bisoprolol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Clozapine</keyword>
	<keyword>Sinustachycardia</keyword>
	<keyword>Heartrate variability</keyword>
	<keyword>Cardiomyopathy</keyword>
</DOC>